Sensus Healthcare Inc (SRTS)
8.92
-0.01
(-0.11%)
USD |
NASDAQ |
Nov 22, 12:52
Sensus Healthcare Gross Profit Margin (Quarterly): 59.28% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 59.28% |
| June 30, 2024 | 58.70% |
| March 31, 2024 | 62.48% |
| December 31, 2023 | 62.31% |
| September 30, 2023 | 51.03% |
| June 30, 2023 | 57.85% |
| March 31, 2023 | 47.51% |
| December 31, 2022 | 63.72% |
| September 30, 2022 | 65.19% |
| June 30, 2022 | 68.34% |
| March 31, 2022 | 69.15% |
| December 31, 2021 | 67.99% |
| September 30, 2021 | 57.94% |
| June 30, 2021 | 61.69% |
| March 31, 2021 | 51.66% |
| December 31, 2020 | 63.37% |
| September 30, 2020 | 41.48% |
| June 30, 2020 | 54.10% |
| March 31, 2020 | 42.23% |
| December 31, 2019 | 64.14% |
| Date | Value |
|---|---|
| September 30, 2019 | 65.81% |
| June 30, 2019 | 66.06% |
| March 31, 2019 | 60.99% |
| December 31, 2018 | 60.16% |
| September 30, 2018 | 65.81% |
| June 30, 2018 | 65.06% |
| March 31, 2018 | 66.16% |
| December 31, 2017 | 66.67% |
| September 30, 2017 | 67.10% |
| June 30, 2017 | 68.72% |
| March 31, 2017 | 65.56% |
| December 31, 2016 | 68.52% |
| September 30, 2016 | 67.64% |
| June 30, 2016 | 64.97% |
| March 31, 2016 | 63.68% |
| December 31, 2015 | 62.77% |
| September 30, 2015 | 67.20% |
| June 30, 2015 | 64.61% |
| March 31, 2015 | 62.47% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
41.48%
Minimum
Sep 2020
69.15%
Maximum
Mar 2022
58.51%
Average
60.49%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | -0.14% |
| InfuSystems Holdings Inc | 53.92% |
| Xtant Medical Holdings Inc | 58.37% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.50% |
| Return on Assets | 16.65% |
| Return on Invested Capital | 18.50% |
| Profit Margin (Quarterly) | 13.75% |
| Operating Margin (Quarterly) | 16.91% |
| Return on Net Operating Assets | 29.08% |